Experimental studies of renal mass augmentation were conducted in the Fisher-->Lewis rat model of late renal allograft failure to assess the injury attributable to inadequate nephron supply in single allografts. Marked proteinuria, glomerulosclerosis and cellular infiltration developed in bilaterally nephrectomized recipients of single allografts at 16 to 20 weeks. By contrast, recipients with two kidney showed markedly reduced indices of allograft injury, irrespective of whether the second kidney was native or transplanted. Micropuncture whether the second kidney was native or transplanted. Micropuncture study of solitary allografts revealed glomerular hyperfiltration and elevated glomerular capillary pressure with marked inter-nephron variation despite normal systemic arterial pressure. In the two-kidney groups, single-nephron GFR and glomerular capillary pressures were essentially normal. These findings provide unambiguous evidence that the cycle of progressive nephron loss characteristic of extensive renal mass ablation operates in single allografts and contributes significantly to injury. The magnitude of allograft protection obtained by augmenting renal mass attests to the importance of nephron supply as a determinant of injury in this model. We conclude that mass-related injury processes may play a potentially major and underappreciated role in the pathogenesis of late renal allograft failure.

Download full-text PDF

Source

Publication Analysis

Top Keywords

renal mass
16
single allografts
12
experimental studies
8
late renal
8
renal allograft
8
allograft failure
8
nephron supply
8
second kidney
8
kidney native
8
native transplanted
8

Similar Publications

Urinary Proteome and Exosome Analysis Protocol for the Discovery of Respiratory Diseases Biomarkers.

Biomolecules

January 2025

BioLympho Research Group, Department of Biochemistry and Molecular Biology, Faculty of Biology-Biological Research Centre (CIBUS), Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.

This study aims to develop a protocol for respiratory disease-associated biomarker discovery by combining urine proteome studies with urinary exosome components analysis (i.e., miRNAs).

View Article and Find Full Text PDF

Chronic kidney disease (CKD) is a progressive condition characterized by declining renal function, with limited biomarkers to predict its progression. The early identification of prognostic biomarkers is crucial for improving patient care and therapeutic strategies. This follow-up study investigated urinary proteomics and clinical outcomes in 18 CKD patients (stages 1-3) and 15 healthy controls using liquid chromatography-mass spectrometry and Mascot-SwissProt for protein identification.

View Article and Find Full Text PDF

The Metabolism of Creatinine and Its Usefulness to Evaluate Kidney Function and Body Composition in Clinical Practice.

Biomolecules

January 2025

Unidad de Investigación Médica en Enfermedades Nefrológicas, Hospital de Especialidades, CMN SXXI, Instituto Mexicano del Seguro Social, Ciudad de México 06720, Mexico.

Serum creatinine levels are the most used clinical marker to estimate renal function as the glomerular function rate because it is simple, fast, and inexpensive. However, creatinine has limitations, as its levels can be influenced by factors such as advanced age, physical activity, protein-rich diets, male gender, medications, and ethnicity. Serum cystatin C and its combination with serum creatinine may serve as an alternative since these factors do not affect it.

View Article and Find Full Text PDF

: Charcot-Marie-Tooth (CMT) disease is an inherited peripheral neuropathy primarily involving motor and sensory neurons. Mutations in INF2, an actin assembly factor, cause two diseases: peripheral neuropathy CMT-DIE (MIM614455) and/or focal segmental glomerulosclerosis (FSGS). These two phenotypes arise from the progressive degeneration affecting podocytes and Schwann cells.

View Article and Find Full Text PDF

Systemic inflammation and oxidative stress are fundamental contributors to the onset of conditions related to childhood obesity, such as cardiovascular (CV) diseases. We aimed to assess CV risk in childhood obesity by examining sex differences in adiposity indices, cardiometabolic profiles, inflammation, and oxidative stress biomarkers. We also aimed to assess the potential of the interferon-inducible T-cell alpha chemoattractant (I-TAC/CXCL11) as a novel biomarker.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!